0 XP   0   0   0

Koninklijke DSM NV ADR
Buy, Hold or Sell?

I guess you are interested in Koninklijke DSM NV ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Dsm

Let's start. I'm going to help you getting a better view of Koninklijke DSM NV ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Koninklijke DSM NV ADR even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Koninklijke DSM NV ADR is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Koninklijke DSM NV ADR. The closing price on 2022-09-30 was $28.40 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Koninklijke DSM NV ADR Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Koninklijke DSM NV ADR.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Dsm earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Dsm to the Specialty Chemicals industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Koninklijke DSM NV ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY3.3%-3.3%
TTM-5Y8.7%-8.7%
5Y8.7%10Y8.3%+0.4%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%-7.3%
TTM-6.2%-6.2%
YOY3.3%7.2%-3.9%
5Y8.7%6.5%+2.2%
10Y8.3%6.5%+1.8%
1.1.2. Return on Assets

Shows how efficient Dsm is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Dsm to the Specialty Chemicals industry mean.
  • 1.8% Return on Assets means that Dsm generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Koninklijke DSM NV ADR:

  • The MRQ is 1.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.8%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.8%-0.4%
TTM1.8%YOY2.2%-0.4%
TTM1.8%5Y2.1%-0.3%
5Y2.1%10Y2.0%+0.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%1.6%-0.3%
TTM1.8%1.5%+0.3%
YOY2.2%1.6%+0.6%
5Y2.1%1.4%+0.7%
10Y2.0%1.5%+0.5%
1.1.3. Return on Equity

Shows how efficient Dsm is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Dsm to the Specialty Chemicals industry mean.
  • 2.3% Return on Equity means the company generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Koninklijke DSM NV ADR:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 3.1%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM3.1%-0.7%
TTM3.1%YOY4.1%-1.0%
TTM3.1%5Y3.9%-0.8%
5Y3.9%10Y3.6%+0.2%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%3.1%-0.8%
TTM3.1%2.9%+0.2%
YOY4.1%3.0%+1.1%
5Y3.9%2.6%+1.3%
10Y3.6%2.8%+0.8%

1.2. Operating Efficiency of Koninklijke DSM NV ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Dsm is operating .

  • Measures how much profit Dsm makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Dsm to the Specialty Chemicals industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Koninklijke DSM NV ADR:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY5.5%-5.5%
TTM-5Y7.9%-7.9%
5Y7.9%10Y8.3%-0.5%
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.1%-9.1%
TTM-8.2%-8.2%
YOY5.5%9.3%-3.8%
5Y7.9%8.0%-0.1%
10Y8.3%6.6%+1.7%
1.2.2. Operating Ratio

Measures how efficient Dsm is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Koninklijke DSM NV ADR:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y1.542-1.542
5Y1.54210Y1.520+0.022
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.627-1.627
TTM-1.555-1.555
YOY-1.448-1.448
5Y1.5421.396+0.146
10Y1.5201.153+0.367

1.3. Liquidity of Koninklijke DSM NV ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Dsm is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Current Ratio of 251.0% means the company has $2.51 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Koninklijke DSM NV ADR:

  • The MRQ is 2.510. The company is able to pay all its short-term debts. +1
  • The TTM is 2.515. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.510TTM2.515-0.006
TTM2.515YOY2.518-0.003
TTM2.5155Y2.439+0.076
5Y2.43910Y2.337+0.102
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5101.750+0.760
TTM2.5151.731+0.784
YOY2.5181.755+0.763
5Y2.4391.689+0.750
10Y2.3371.457+0.880
1.3.2. Quick Ratio

Measures if Dsm is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Specialty Chemicals industry mean)
  • A Quick Ratio of 86.5% means the company can pay off $0.86 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Koninklijke DSM NV ADR:

  • The MRQ is 0.865. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.761. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.865TTM0.761+0.104
TTM0.761YOY0.730+0.031
TTM0.7615Y0.958-0.197
5Y0.95810Y0.944+0.014
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8650.792+0.073
TTM0.7610.801-0.040
YOY0.7300.874-0.144
5Y0.9580.807+0.151
10Y0.9440.804+0.140

1.4. Solvency of Koninklijke DSM NV ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Dsm assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Debt to Asset Ratio of 0.42 means that Dsm assets are financed with 41.7% credit (debt) and the remaining percentage (100% - 41.7%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Koninklijke DSM NV ADR:

  • The MRQ is 0.417. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.419. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.417TTM0.419-0.001
TTM0.419YOY0.467-0.049
TTM0.4195Y0.443-0.024
5Y0.44310Y0.453-0.011
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4170.442-0.025
TTM0.4190.428-0.009
YOY0.4670.432+0.035
5Y0.4430.429+0.014
10Y0.4530.435+0.018
1.4.2. Debt to Equity Ratio

Measures if Dsm is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A Debt to Equity ratio of 72.2% means that company has $0.72 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Koninklijke DSM NV ADR:

  • The MRQ is 0.722. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.726. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.722TTM0.726-0.004
TTM0.726YOY0.890-0.163
TTM0.7265Y0.807-0.080
5Y0.80710Y0.847-0.040
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7220.800-0.078
TTM0.7260.762-0.036
YOY0.8900.775+0.115
5Y0.8070.780+0.027
10Y0.8470.812+0.035

2. Market Valuation of Koninklijke DSM NV ADR

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Dsm.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 5.59 means the investor is paying $5.59 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Koninklijke DSM NV ADR:

  • The EOD is 4.419. Very good. +2
  • The MRQ is 5.594. Very good. +2
  • The TTM is 5.831. Very good. +2
Trends
Current periodCompared to+/- 
EOD4.419MRQ5.594-1.175
MRQ5.594TTM5.831-0.236
TTM5.831YOY9.604-3.773
TTM5.8315Y6.495-0.665
5Y6.49510Y5.648+0.847
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD4.41913.857-9.438
MRQ5.59414.556-8.962
TTM5.83118.291-12.460
YOY9.60416.594-6.990
5Y6.49517.460-10.965
10Y5.64819.018-13.370
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Dsm.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Koninklijke DSM NV ADR:

  • The MRQ is -0.552. Very Bad. -2
  • The TTM is -0.088. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.552TTM-0.088-0.463
TTM-0.088YOY0.433-0.521
TTM-0.0885Y-0.053-0.035
5Y-0.05310Y-0.0530.000
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.5520.023-0.575
TTM-0.0880.041-0.129
YOY0.4330.044+0.389
5Y-0.0530.003-0.056
10Y-0.0530.014-0.067

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Dsm is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Specialty Chemicals industry mean).
  • A PB ratio of 0.63 means the investor is paying $0.63 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Koninklijke DSM NV ADR:

  • The EOD is 0.500. Very good. +2
  • The MRQ is 0.633. Very good. +2
  • The TTM is 0.879. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.500MRQ0.633-0.133
MRQ0.633TTM0.879-0.246
TTM0.879YOY0.971-0.092
TTM0.8795Y0.478+0.401
5Y0.47810Y0.416+0.062
Compared to industry (Specialty Chemicals)
PeriodCompanyIndustry (mean)+/- 
EOD0.5001.943-1.443
MRQ0.6332.148-1.515
TTM0.8792.421-1.542
YOY0.9712.163-1.192
5Y0.4782.117-1.639
10Y0.4161.647-1.231

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Koninklijke DSM NV ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--56.79153.655+6%44.793+27%26.323+116%22.889+148%
Book Value Per Share Growth--2.4631.904+29%1.595+54%5.163-52%5.163-52%
Current Ratio--2.5102.5150%2.5180%2.439+3%2.337+7%
Debt To Asset Ratio--0.4170.4190%0.467-11%0.443-6%0.453-8%
Debt To Equity Ratio--0.7220.726-1%0.890-19%0.807-10%0.847-15%
Dividend Per Share--0.4970.496+0%0.547-9%0.390+28%0.390+28%
Eps--1.2981.607-19%1.788-27%1.399-7%1.678-23%
Eps Growth---10.14284.933-112%45.261-122%11.576-188%11.576-188%
Gains Per Share--2.9602.400+23%2.141+38%5.552-47%5.552-47%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%0.033-100%0.087-100%0.083-100%
Operating Margin----0%0.055-100%0.079-100%0.083-100%
Operating Ratio----0%-0%1.542-100%1.520-100%
Pb Ratio0.500-27%0.6330.879-28%0.971-35%0.478+32%0.416+52%
Pe Ratio4.419-27%5.5945.831-4%9.604-42%6.495-14%5.648-1%
Peg Ratio---0.552-0.088-84%0.433-228%-0.053-90%-0.053-90%
Price Per Share28.400-27%35.95046.843-23%43.481-17%34.291+5%32.001+12%
Quick Ratio--0.8650.761+14%0.730+18%0.958-10%0.944-8%
Return On Assets--0.0130.018-24%0.022-39%0.021-37%0.020-32%
Return On Equity--0.0230.031-24%0.041-43%0.039-40%0.036-36%
 EOD+3 -0MRQTTM+11 -5YOY+10 -85Y+8 -1110Y+8 -11

3.2. Fundamental Score

Let's check the fundamental score of Koninklijke DSM NV ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154.419
Price to Book Ratio (EOD)Between0-10.500
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.865
Current Ratio (MRQ)Greater than12.510
Debt to Asset Ratio (MRQ)Less than10.417
Debt to Equity Ratio (MRQ)Less than10.722
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.013
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Koninklijke DSM NV ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.644
Ma 20Greater thanMa 5029.552
Ma 50Greater thanMa 10033.621
Ma 100Greater thanMa 20035.635
OpenGreater thanClose28.290
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets16,853,000
Total Liabilities7,030,000
Total Stockholder Equity9,731,000
 As reported
Total Liabilities 7,030,000
Total Stockholder Equity+ 9,731,000
Total Assets = 16,853,000

Assets

Total Assets16,853,000
Total Current Assets7,579,000
Long-term Assets7,579,000
Total Current Assets
Cash And Cash Equivalents 792,000
Short-term Investments 838,000
Net Receivables 1,774,000
Inventory 2,394,000
Other Current Assets 1,781,000
Total Current Assets  (as reported)7,579,000
Total Current Assets  (calculated)7,579,000
+/-0
Long-term Assets
Property Plant Equipment 3,570,000
Other Assets 246,000
Long-term Assets  (as reported)9,274,000
Long-term Assets  (calculated)3,816,000
+/- 5,458,000

Liabilities & Shareholders' Equity

Total Current Liabilities3,020,000
Long-term Liabilities4,010,000
Total Stockholder Equity9,731,000
Total Current Liabilities
Accounts payable 1,541,000
Other Current Liabilities 1,361,000
Total Current Liabilities  (as reported)3,020,000
Total Current Liabilities  (calculated)2,902,000
+/- 118,000
Long-term Liabilities
Other Liabilities 1,025,000
Long-term Liabilities Other 189,000
Long-term Liabilities  (as reported)4,010,000
Long-term Liabilities  (calculated)1,214,000
+/- 2,796,000
Total Stockholder Equity
Common Stock328,000
Retained Earnings 8,552,000
Other Stockholders Equity 595,000
Total Stockholder Equity (as reported)9,731,000
Total Stockholder Equity (calculated)9,475,000
+/- 256,000
Other
Net Invested Capital 9,731,000
Net Tangible Assets 4,539,000
Net Working Capital 4,559,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
13,667,000
13,927,000
14,210,466
15,674,058
15,374,084
16,272,604
15,451,583
15,490,854
15,646,937
14,289,000
13,901,000
13,812,000
13,443,000
13,814,000
14,827,000
14,272,000
14,364,000
0
15,095,000
0
16,013,000
0
16,853,000
16,853,000016,013,000015,095,000014,364,00014,272,00014,827,00013,814,00013,443,00013,812,00013,901,00014,289,00015,646,93715,490,85415,451,58316,272,60415,374,08415,674,05814,210,46613,927,00013,667,000
   > Total Current Assets 
5,317,000
5,541,000
5,899,223
7,389,417
6,523,358
7,336,696
6,961,127
6,998,148
7,237,899
6,553,000
6,266,000
5,792,000
5,224,000
5,639,000
5,890,000
6,305,000
5,425,000
5,811,000
5,811,000
6,129,000
6,129,000
7,579,000
7,579,000
7,579,0007,579,0006,129,0006,129,0005,811,0005,811,0005,425,0006,305,0005,890,0005,639,0005,224,0005,792,0006,266,0006,553,0007,237,8996,998,1486,961,1277,336,6966,523,3587,389,4175,899,2235,541,0005,317,000
       Cash And Cash Equivalents 
721,000
682,000
421,618
1,884,313
1,079,621
1,335,958
946,229
1,154,202
1,469,374
2,473,000
2,286,000
1,779,000
1,488,000
1,591,000
1,955,000
1,686,000
871,000
0
1,640,000
0
1,561,000
0
792,000
792,00001,561,00001,640,0000871,0001,686,0001,955,0001,591,0001,488,0001,779,0002,286,0002,473,0001,469,3741,154,202946,2291,335,9581,079,6211,884,313421,618682,000721,000
       Short-term Investments 
996,000
1,002,000
992,916
1,185,029
1,145,671
1,173,576
1,170,857
1,158,833
1,464,786
1,430,000
1,149,000
853,000
688,000
195,000
655,000
40,000
43,000
0
215,000
0
489,000
0
838,000
838,0000489,0000215,000043,00040,000655,000195,000688,000853,0001,149,0001,430,0001,464,7861,158,8331,170,8571,173,5761,145,6711,185,029992,9161,002,000996,000
       Net Receivables 
1,744,000
1,896,000
1,967,550
2,055,614
2,027,141
2,419,732
2,293,994
2,184,533
1,992,429
1,836,000
1,742,000
1,719,000
1,696,000
1,890,000
1,741,000
1,505,000
1,483,000
1,741,000
1,741,000
1,691,000
1,691,000
1,774,000
1,774,000
1,774,0001,774,0001,691,0001,691,0001,741,0001,741,0001,483,0001,505,0001,741,0001,890,0001,696,0001,719,0001,742,0001,836,0001,992,4292,184,5332,293,9942,419,7322,027,1412,055,6141,967,5501,896,0001,744,000
       Inventory 
1,899,000
1,995,000
2,116,088
2,152,998
2,219,287
2,369,295
2,347,533
2,309,562
2,286,075
2,065,000
2,071,000
2,118,000
2,019,000
2,137,000
2,177,000
1,953,000
1,879,000
2,095,000
2,095,000
2,297,000
2,297,000
2,394,000
2,394,000
2,394,0002,394,0002,297,0002,297,0002,095,0002,095,0001,879,0001,953,0002,177,0002,137,0002,019,0002,118,0002,071,0002,065,0002,286,0752,309,5622,347,5332,369,2952,219,2872,152,9982,116,0881,995,0001,899,000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
7,736,000
7,635,000
8,020,000
8,219,000
8,175,000
8,937,000
7,967,000
8,939,000
0
9,284,000
0
9,884,000
0
9,274,000
9,274,00009,884,00009,284,00008,939,0007,967,0008,937,0008,175,0008,219,0008,020,0007,635,0007,736,000000000000
       Property Plant Equipment 
3,507,000
3,512,000
3,638,026
3,697,055
3,978,624
3,995,571
3,902,467
3,911,785
4,027,300
3,798,000
3,764,000
3,932,000
4,040,000
4,012,000
4,035,000
3,647,000
3,774,000
3,754,000
3,754,000
3,957,000
3,957,000
3,570,000
3,570,000
3,570,0003,570,0003,957,0003,957,0003,754,0003,754,0003,774,0003,647,0004,035,0004,012,0004,040,0003,932,0003,764,0003,798,0004,027,3003,911,7853,902,4673,995,5713,978,6243,697,0553,638,0263,512,0003,507,000
       Goodwill 
1,958,000
0
0
0
2,321,364
0
0
0
2,189,722
0
0
0
2,283,000
0
0
0
2,515,000
0
0
0
2,951,000
0
0
002,951,0000002,515,0000002,283,0000002,189,7220002,321,3640001,958,000
       Long Term Investments 
636,000
1,000
855,804
789,628
379,488
893,099
690,177
709,655
423,262
1,345,145
1,377,255
1,076,343
957,499
0
0
0
0
0
0
0
0
0
0
0000000000957,4991,076,3431,377,2551,345,145423,262709,655690,177893,099379,488789,628855,8041,000636,000
       Intangible Assets 
3,363,000
3,380,000
3,451,782
3,443,623
1,351,027
3,662,197
3,543,994
3,565,640
1,354,669
10,258,302
10,833,738
8,113,970
1,232,000
0
0
0
1,940,000
0
0
0
2,359,000
0
0
002,359,0000001,940,0000001,232,0008,113,97010,833,73810,258,3021,354,6693,565,6403,543,9943,662,1971,351,0273,443,6233,451,7823,380,0003,363,000
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
7,736,000
7,635,000
8,020,000
8,219,000
8,175,000
0
0
0
0
0
0
0
0
0
0000000008,175,0008,219,0008,020,0007,635,0007,736,000000000000
> Total Liabilities 
7,149,000
7,253,000
7,477,148
7,514,960
6,889,636
7,352,688
6,834,264
6,664,737
6,682,725
6,063,000
6,061,000
5,650,000
5,608,000
6,151,000
7,447,000
6,858,000
6,877,000
0
6,500,000
0
6,616,000
0
7,030,000
7,030,00006,616,00006,500,00006,877,0006,858,0007,447,0006,151,0005,608,0005,650,0006,061,0006,063,0006,682,7256,664,7376,834,2647,352,6886,889,6367,514,9607,477,1487,253,0007,149,000
   > Total Current Liabilities 
3,346,000
3,392,000
3,393,510
3,390,825
2,675,633
3,064,338
2,770,019
2,598,981
2,949,071
2,676,000
2,695,000
2,207,000
2,163,000
2,698,000
2,847,000
2,346,000
2,264,000
2,329,000
2,329,000
2,431,000
2,431,000
3,020,000
3,020,000
3,020,0003,020,0002,431,0002,431,0002,329,0002,329,0002,264,0002,346,0002,847,0002,698,0002,163,0002,207,0002,695,0002,676,0002,949,0712,598,9812,770,0193,064,3382,675,6333,390,8253,393,5103,392,0003,346,000
       Short-term Debt 
1,167,000
1,098,000
3,873,400
930,424
9,607
108,254
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000108,2549,607930,4243,873,4001,098,0001,167,000
       Short Long Term Debt 
1,167,000
1,098,000
3,873,400
930,424
9,607
108,254
100,093
127,344
352,145
429,000
1,313,587
298,064
140,000
0
0
0
60,000
0
0
0
56,000
0
0
0056,00000060,000000140,000298,0641,313,587429,000352,145127,344100,093108,2549,607930,4243,873,4001,098,0001,167,000
       Accounts payable 
1,553,000
1,654,000
1,541,362
1,639,094
1,738,922
2,024,849
1,726,024
1,611,484
1,634,549
1,471,000
1,452,000
1,365,000
1,338,000
1,554,000
1,474,000
1,178,000
1,207,000
1,448,000
1,448,000
1,561,000
1,561,000
1,541,000
1,541,000
1,541,0001,541,0001,561,0001,561,0001,448,0001,448,0001,207,0001,178,0001,474,0001,554,0001,338,0001,365,0001,452,0001,471,0001,634,5491,611,4841,726,0242,024,8491,738,9221,639,0941,541,3621,654,0001,553,000
       Other Current Liabilities 
627,000
640,000
886,654
776,722
331,452
883,257
898,510
815,003
375,086
539,000
584,000
466,000
238,000
650,000
725,000
810,000
555,000
722,000
722,000
351,000
351,000
1,361,000
1,361,000
1,361,0001,361,000351,000351,000722,000722,000555,000810,000725,000650,000238,000466,000584,000539,000375,086815,003898,510883,257331,452776,722886,654640,000627,000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
3,387,000
3,366,000
3,443,000
3,445,000
3,453,000
4,600,000
4,512,000
4,613,000
0
4,171,000
0
4,185,000
0
4,010,000
4,010,00004,185,00004,171,00004,613,0004,512,0004,600,0003,453,0003,445,0003,443,0003,366,0003,387,000000000000
       Capital Lease Obligations Min Short Term Debt
-1,167,000
-1,098,000
-3,873,400
-930,424
-9,607
-108,254
0
0
0
0
0
0
236,000
0
0
0
215,000
0
0
0
195,000
0
0
00195,000000215,000000236,000000000-108,254-9,607-930,424-3,873,400-1,098,000-1,167,000
       Other Liabilities 
819,000
827,000
1,131,170
1,135,750
1,150,474
1,151,433
1,075,419
1,092,846
1,127,552
954,000
934,000
984,000
981,000
983,000
1,108,000
1,063,000
1,134,000
1,182,000
1,182,000
1,196,000
1,196,000
1,025,000
1,025,000
1,025,0001,025,0001,196,0001,196,0001,182,0001,182,0001,134,0001,063,0001,108,000983,000981,000984,000934,000954,0001,127,5521,092,8461,075,4191,151,4331,150,4741,135,7501,131,170827,000819,000
       Deferred Long Term Liability 
293,000
255,000
349,634
356,682
19,215
383,811
0
0
10,323
0
0
0
7,000
0
0
0
0
0
0
0
0
0
0
00000000007,00000010,32300383,81119,215356,682349,634255,000293,000
> Total Stockholder Equity
6,404,000
6,561,000
6,619,059
8,045,289
8,360,754
8,875,630
8,575,419
8,785,599
8,926,359
8,169,000
7,786,000
8,063,000
7,731,000
7,560,000
7,279,000
7,323,000
7,399,000
0
8,516,000
0
9,318,000
0
9,731,000
9,731,00009,318,00008,516,00007,399,0007,323,0007,279,0007,560,0007,731,0008,063,0007,786,0008,169,0008,926,3598,785,5998,575,4198,875,6308,360,7548,045,2896,619,0596,561,0006,404,000
   Common Stock
338,000
6,134,000
6,619,059
8,045,289
405,908
8,875,630
8,575,419
8,785,599
387,704
8,169,000
7,786,000
8,063,000
338,000
7,560,000
7,279,000
7,323,000
338,000
8,516,000
8,516,000
328,000
328,000
328,000
328,000
328,000328,000328,000328,0008,516,0008,516,000338,0007,323,0007,279,0007,560,000338,0008,063,0007,786,0008,169,000387,7048,785,5998,575,4198,875,630405,9088,045,2896,619,0596,134,000338,000
   Retained Earnings 
5,188,000
0
0
0
8,084,544
0
0
0
8,466,391
0
0
0
7,713,000
0
0
0
7,791,000
0
0
8,540,000
8,540,000
8,552,000
8,552,000
8,552,0008,552,0008,540,0008,540,000007,791,0000007,713,0000008,466,3910008,084,5440005,188,000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
396,000
0
0
0
-238,982
0
0
0
-63,088
0
0
0
96,000
0
0
0
-243,000
0
0
156,000
156,000
595,000
595,000
595,000595,000156,000156,00000-243,00000096,000000-63,088000-238,982000396,000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue9,204,000
Cost of Revenue-6,040,000
Gross Profit3,164,0003,164,000
 
Operating Income (+$)
Gross Profit3,164,000
Operating Expense-8,179,000
Operating Income1,025,000-5,015,000
 
Operating Expense (+$)
Research Development323,000
Selling General Administrative1,787,000
Selling And Marketing Expenses-
Operating Expense8,179,0002,110,000
 
Net Interest Income (+$)
Interest Income3,000
Interest Expense-110,000
Net Interest Income-99,000-107,000
 
Pretax Income (+$)
Operating Income1,025,000
Net Interest Income-99,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)915,0001,025,000
EBIT - interestExpense = 913,000
1,844,000
1,786,000
Interest Expense110,000
Earnings Before Interest and Taxes (ebit)1,023,0001,025,000
Earnings Before Interest and Taxes (ebitda)1,706,000
 
After tax Income (+$)
Income Before Tax915,000
Tax Provision-168,000
Net Income From Continuing Ops1,089,000747,000
Net Income1,676,000
Net Income Applicable To Common Shares1,670,000
 
Non-recurring Events
Discontinued Operations591,000
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses29,000
Total Other Income/Expenses Net-99,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
SKUE.OL
4 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SKUE.OL.

SKUE.OL Daily Candlestick Chart
AERS.LSE
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AERS.LSE.

AERS.LSE Daily Candlestick Chart
VIA.CC
5 hours ago

I found you a Death Cross on the daily chart of VIA.CC.

VIA.CC Daily Candlestick Chart
VELO.CC
5 hours ago

I found you a RSI Bearish Hidden Divergence on the daily chart of VELO.CC.

VELO.CC Daily Candlestick Chart
vBUSD.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of vBUSD.CC.

vBUSD.CC Daily Candlestick Chart
UNW.CC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of UNW.CC.

UNW.CC Daily Candlestick Chart
TWTR.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TWTR.CC.

TWTR.CC Daily Candlestick Chart
TMN.CC
5 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of TMN.CC.

TMN.CC Daily Candlestick Chart
TEL.CC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TEL.CC.

TEL.CC Daily Candlestick Chart
WFAFY.PINK
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of WFAFY.PINK.

WFAFY.PINK Daily Candlestick Chart
BOCT.BATS
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BOCT.BATS.

BOCT.BATS Daily Candlestick Chart
BATT.NYSE ARC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of BATT.NYSE ARC.

BATT.NYSE ARC Daily Candlestick Chart
ASXFY.PINK
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ASXFY.PINK.

ASXFY.PINK Daily Candlestick Chart
ARKQ.BATS
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ARKQ.BATS.

ARKQ.BATS Daily Candlestick Chart
AGZ.NYSE ARC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of AGZ.NYSE ARC.

AGZ.NYSE ARC Daily Candlestick Chart
ADDDF.OTCQX
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ADDDF.OTCQX.

ADDDF.OTCQX Daily Candlestick Chart
ACWI.NASDAQ
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ACWI.NASDAQ.

ACWI.NASDAQ Daily Candlestick Chart
JQUA.NYSE ARC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of JQUA.NYSE ARC.

JQUA.NYSE ARC Daily Candlestick Chart
ZIG.NYSE ARC
5 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ZIG.NYSE ARC.

ZIG.NYSE ARC Daily Candlestick Chart
YINN.NYSE ARC
5 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of YINN.NYSE ARC.

YINN.NYSE ARC Daily Candlestick Chart
XSVM.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XSVM.NYSE ARC.

XSVM.NYSE ARC Daily Candlestick Chart
XOUT.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XOUT.NYSE ARC.

XOUT.NYSE ARC Daily Candlestick Chart
XNTK.NYSE ARC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XNTK.NYSE ARC.

XNTK.NYSE ARC Daily Candlestick Chart